MTCH2 Suppresses Thermogenesis by Regulating Autophagy in Adipose Tissue

Xin-Yuan Zhao1, Ben-Chi Zhao1, Hui-Lin Li1

  • 1Laboratory of Metabolism and Aging, School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China.

Insights

Mitochondrial carrier homolog 2 (MTCH2) negatively regulates energy expenditure. Depleting MTCH2 in mice combats obesity by boosting adipose tissue thermogenesis and improving metabolic health, revealing a new therapeutic target.

Area of Science:

  • Metabolic disease research
  • Adipose tissue biology
  • Obesity mechanisms

Background:

  • Adipose tissue thermogenesis, regulated by uncoupling protein 1 (UCP1), is crucial for energy expenditure and obesity management.
  • Mechanisms suppressing thermogenesis in obesity remain incompletely understood.
  • Mitochondrial carrier homolog 2 (MTCH2) is an obesity susceptibility gene with an unclear role in energy homeostasis.

Purpose of the Study:

  • To investigate the role of MTCH2 in regulating energy homeostasis and adipose tissue thermogenesis.
  • To identify MTCH2 as a potential therapeutic target for obesity and related metabolic disorders.

Main Methods:

  • Utilized a combination of genetic manipulation (adipose-specific MTCH2 depletion in mice), high-fat diet (HFD) models, and integrated multi-omics analyses (RNA sequencing and proteomics).
  • Assessed metabolic parameters, thermogenesis markers (UCP1), mitochondrial biogenesis, and lipolysis in brown adipose tissue (BAT) and subcutaneous white adipose tissue (scWAT).
  • Investigated the molecular mechanism linking MTCH2 to thermogenesis regulation, focusing on autophagy and Bcl-2 interactions.

Main Results:

  • Adipose-specific MTCH2 depletion in mice conferred protection against HFD-induced obesity and metabolic dysfunction.
  • MTCH2 deficiency enhanced energy expenditure by stimulating BAT thermogenesis and promoting scWAT browning.
  • Key findings include upregulated UCP1, increased mitochondrial biogenesis, enhanced lipolysis, and MTCH2's role as a negative regulator of autophagy via a Bcl-2-dependent pathway.

Conclusions:

  • MTCH2 acts as a critical suppressor of thermogenesis and energy homeostasis.
  • MTCH2 negatively regulates autophagy through a Bcl-2-dependent mechanism, impacting adipose tissue function.
  • MTCH2 represents a novel therapeutic target for enhancing energy expenditure and treating obesity and metabolic diseases.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
172
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K